$379 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 67 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 107.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Buy | Gilead Sciences Inc | $27,724,000 | +10.6% | 402,784 | +3.9% | 7.32% | +10.4% |
| ALNY | Buy | Alnylam Pharmaceuticals Inc | $25,239,000 | +64.3% | 149,000 | +36.9% | 6.66% | +64.0% |
| SGEN | Buy | SEAGEN INC | $22,868,000 | +23.9% | 145,000 | +9.0% | 6.04% | +23.6% |
| HZNP | New | HORIZON THERAPEUTICS PUB LTD | $22,274,000 | – | 237,873 | +100.0% | 5.88% | – |
| PTCT | Buy | PTC Therapuetics COM | $18,948,000 | -1.9% | 449,000 | +10.0% | 5.00% | -2.1% |
| AMGN | Buy | Amgen Inc | $12,431,000 | +16.2% | 51,000 | +18.6% | 3.28% | +16.0% |
| INCY | Buy | Incyte Corp | $11,509,000 | +81.6% | 136,860 | +75.5% | 3.04% | +81.2% |
| QURE | Buy | UNIQURE NV | $9,705,000 | +2.3% | 315,500 | +11.9% | 2.56% | +2.1% |
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $9,481,000 | +23.0% | 121,541 | +49.1% | 2.50% | +22.7% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $7,768,000 | +74.6% | 43,300 | +62.8% | 2.05% | +74.3% |
| KALV | Buy | Kalvista Pharmaceuticals Inc | $6,786,000 | +23.7% | 283,233 | +32.0% | 1.79% | +23.5% |
| SUPN | New | SUPERNUS PHARMACEUTICALS INC | $6,233,000 | – | 202,436 | +100.0% | 1.65% | – |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $5,731,000 | +150.8% | 60,100 | +199.0% | 1.51% | +150.5% |
| HRMY | New | HARMONY BIOSCIENCES HLDGS IN | $4,686,000 | – | 166,000 | +100.0% | 1.24% | – |
| HALO | Buy | Halozyme Therapeutics Inc | $3,752,000 | +159.8% | 82,633 | +138.6% | 0.99% | +159.4% |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $3,553,000 | – | 20,000 | +100.0% | 0.94% | – |
| INSM | Buy | INSMED INC | $2,849,000 | +149.0% | 100,100 | +197.9% | 0.75% | +148.2% |
| DYN | Buy | DYNE THERAPEUTICS INC | $2,840,000 | +95.5% | 135,000 | +43.8% | 0.75% | +95.3% |
| HCM | New | HUTCHMED CHINA LTDsponsored ads | $2,671,000 | – | 68,000 | +100.0% | 0.70% | – |
| KDNY | New | CHINOOK THERAPEUTICS INC | $2,412,000 | – | 170,821 | +100.0% | 0.64% | – |
| ZLAB | New | ZAI LAB LTDadr | $2,264,000 | – | 12,800 | +100.0% | 0.60% | – |
| NKTX | New | NKARTA INC | $2,214,000 | – | 70,000 | +100.0% | 0.58% | – |
| GH | New | GUARDANT HEALTH INC | $2,112,000 | – | 17,000 | +100.0% | 0.56% | – |
| ENTA | New | ENANTA PHARMACEUTICALS INC | $1,498,000 | – | 34,047 | +100.0% | 0.40% | – |
| ALKS | New | ALKERMES PLC | $1,103,000 | – | 45,000 | +100.0% | 0.29% | – |
| IMVT | New | IMMUNOVANT INC | $634,000 | – | 60,000 | +100.0% | 0.17% | – |
| ARDX | New | ARDELYX INC | $591,000 | – | 78,000 | +100.0% | 0.16% | – |
| BDTX | New | BLACK DIAMOND THERAPEUTICS I | $535,000 | – | 44,000 | +100.0% | 0.14% | – |
| XENE | New | XENON PHARMACEUTICALS INC | $474,000 | – | 25,500 | +100.0% | 0.12% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.